Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.96 USD | -3.36% | -6.80% | -8.57% |
01/04 | Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
26/03 | Transcript : Quince Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-8.57% | 41.49M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+46.73% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- QNCX Stock
- News Quince Therapeutics, Inc.
- HC Wainwright Adjusts Cortexyme's Price Target to $30 From $200, Reiterates Buy Rating